The Evaluation of Kidney Function in Elderly Individuals Under Renin Angiotensin Aldosterone System Inhibitor Therapy

RAAS blockers in Elderly and eGFR


Abstract views: 170 / PDF downloads: 68

Authors

DOI:

https://doi.org/10.5281/zenodo.7772719

Keywords:

RAAS blockers,, GFR, hydration, fasting, biochemical assessment

Abstract

Background: We aim to investigate the impact of hydration status (12-hour fasting or 12-hour water-free fasting) on the estimated glomerular filtration rate (eGFR) and serum potassium in renin-angiotensin-aldosterone (RAAS) blocker users during biochemical assessments.
Material and Methods: A total of 90 individuals were enrolled in this longitudinal study. 57 of those were advised to be hydrated for at least 1 L before the next hospital visit. 33 of 90 individuals remained in the non-hydrated group and their blood samples were evaluated following 12-hour fasting. Hypertensive patients were divided according to the antihypertensive medicine group (RAAS blockers, RAAS blockers + diuretics, and others). eGFR, serum potassium, calcium, magnesium, albumin, and glucose levels were compared between hydrated and non-hydrated individuals.
Results: The mean age was 48.21±16.59 in hydrated and 47.42±17.12 in non-hydrated groups (p=0.831). Hypertension prevalence was 59.6% in the hydrated group and 54.5% in non hydrated group. In the RAAS blocker users, following hydration, eGFR elevated up to 8-11 ml/dk (p<0.05). In the hydrated individuals with age ≥65 years and receiving RAAS blockers, the increment in eGFR was most prominent (p=0.002). Hydration increased eGFR in individuals with RAAS blockers-free and nonhypertensive, however, those increments were not statistically significant (p>0.05). Similarly, serum potassium levels decreased following hydration in RAAS blocker users (p<0.05). Hyperkalemia (serum potassium ≥ 5 mEq/L) risk decreased from 9.2 fold to 6.16 fold following hydration (p<0.05).
Conclusion: Twelve-hour fasting is associated with lower eGFR and higher serum potassium levels. An assessment of eGFR and serum potassium following hydration (12-hour water-free fasting) is beneficial for accurately assessing. This impact is more prominent in RAAS blocker users, especially in individuals ≥65 years.

References

Steiner MJ, Skinner AC, Perrin EM. Fasting might not be necessary before lipid screening: a nationally representative cross-sectional study. Pediatrics. 2011;128(3):463-470. doi:10.1542/peds.2011-0844

Castro Cabezas M, Burggraaf B, Klop B. Is it time to break the fast?-a paradigm shift in clinical lipidology. Ann Transl Med. 2016;4(21):430. doi:10.21037/atm.2016.09.42

Ferreira TDS, Antunes VP, Leal PM, Sanjuliani AF, Klein MRST. The influence of dietary and supplemental calcium on postprandial effects of a high-fat meal on lipaemia, glycemia, C-reactive protein and adiponectin in obese women. Br J Nutr. 2017;118(8):607-615. doi:10.1017/S0007114517002525

Anderson LN, Maguire JL, Lebovic G, et al. Duration of Fasting, Serum Lipids, and Metabolic Profile in Early Childhood. J Pediatr. 2017;180:47-52.e1. doi:10.1016/j.jpeds.2016.09.005

Jackevicius CA, Wong J, Aroustamian I, Gee M, Mody FV. Rates and predictors of ACE inhibitor discontinuation subsequent to elevated serum creatinine: a retrospective cohort study. BMJ Open. 2014;4(8):e005181. doi:10.1136/bmjopen-2014-005181

Ahmed A. Use of angiotensin-converting enzyme inhibitors in patients with heart failure and renal insufficiency: how concerned should we be by the rise in serum creatinine?. J Am Geriatr Soc. 2002;50(7):1297-1300. doi:10.1046/j.1532-5415.2002.50321.x

Aloia JF, Vaswani A, Flaster E, Ma R. Relationship of body water compartments to age, race, and fat-free mass. J Lab Clin Med. 1998;132(6):483-490. doi:10.1016/s0022-2143(98)90126-3

Schoeller DA. Changes in total body water with age. Am J Clin Nutr. 1989;50(5 Suppl):1176-1235. doi:10.1093/ajcn/50.5.1176.

Miller HJ. Dehydration in the Older Adult. J Gerontol Nurs. 2015;41(9):8-13. doi:10.3928/00989134-20150814-02

Fitzsimons JT. Angiotensin, thirst, and sodium appetite. Physiol Rev. 1998;78(3):583-686. doi:10.1152/physrev.1998.78.3.583

Coble JP, Grobe JL, Johnson AK, Sigmund CD. Mechanisms of brain renin angiotensin system-induced drinking and blood pressure: importance of the subfornical organ. Am J Physiol Regul Integr Comp Physiol. 2015;308(4):R238-R249. doi:10.1152/ajpregu.00486.2014

Santoro A, Mandreoli M. G Ital Nefrol. 2018;35(3):2018-vol3.

Perazella MA. Hyperkalemia in the elderly: a group at high risk. Conn Med. 1996;60(4):195-198.

Turgutalp K, Bardak S, Helvacı I, et al. Community-acquired hyperkalemia in elderly patients: risk factors and clinical outcomes. Ren Fail. 2016;38(9):1405-1412. doi:10.1080/0886022X.2016.1216714

Schlanger LE, Bailey JL, Sands JM. Electrolytes in the aging. Adv Chronic Kidney Dis. 2010;17(4):308-319. doi:10.1053/j.ackd.2010.03.008

Wetmore JB, Yan H, Horne L, Peng Y, Gilbertson DT. Risk of hyperkalemia from renin-angiotensin-aldosterone system inhibitors and factors associated with treatment discontinuities in a real-world population. Nephrol Dial Transplant. 2021;36(5):826-839. doi:10.1093/ndt/gfz263

Downloads

Published

2023-03-27

How to Cite

Küçüker, S., Çiçek Demir, C., Demir, R., & Gençer, V. (2023). The Evaluation of Kidney Function in Elderly Individuals Under Renin Angiotensin Aldosterone System Inhibitor Therapy: RAAS blockers in Elderly and eGFR. Journal of European Internal Medicine Professionals, 1(2). https://doi.org/10.5281/zenodo.7772719